Gainers
- ECMOHO Limited MOHO shares rose 47% to $0.2149 in pre-market trading.
- Vaccitech plc VACC shares rose 25% to $5.89 in pre-market trading. Vaccitech recently posted Q2 earnings of $0.41 per share.
- AIM ImmunoTech Inc. AIM rose 23.8% to $0.87 in pre-market trading. AIM Immunotech recently reported commencement of Phase 2 study of Ampligen for the treatment of pancreatic cancer.
- Snowflake Inc. SNOW rose 17.4% to $187.18 in pre-market trading after the company reported better-than-expected Q2 sales results and issued product revenue guidance.
- Allarity Therapeutics, Inc. ALLR rose 16.4% to $1.42 in pre-market trading after gaining 5% on Wednesday. Ladenburg Thalmann recently downgraded Allarity Therapeutics from Buy to Neutral.
- FREYR Battery FREY rose 14.7% to $12.14 in pre-market trading. FREYR Battery entered into strategic partnership with Hana Technology.
- Athersys, Inc. ATHX rose 13.4% to $0.2029 in pre-market trading. Athersys recently reported closing of $12 million registered direct offering.
- ATRenew Inc. RERE rose 10.6% to $3.77 in pre-market trading after jumping 19% on Wednesday. ATRenew posted Q2 loss of $0.01 per share.
- Pulmatrix, Inc.PULM rose 9.6% to $5.92 in pre-market trading after jumping around 18% on Wednesday. Pulmonx recently said it sees FY22 sales of $55 million to $60 million.
- Autodesk, Inc. ADSK rose 9.5% to $234.86 in pre-market trading after the company reported better-than-expected Q2 results and issued FY23 guidance above estimates.
- BYND Cannasoft Enterprises Inc. BCAN shares rose 9.4% to $5.00 in pre-market trading. BYND Cannasoft recently posted Q2 sales of $207,653.
- 9F Inc. JFU rose 9.3% to $0.47 in pre-market trading after dropping 28% on Wednesday.
- Agrify Corporation AGFY shares rose 8.6% to $0.96 in pre-market trading. Agrify recently released financial results for the second quarter, revealing revenue of $19.3 million.
- BeiGene, Ltd. BGNE rose 7.8% to $190.00 in pre-market trading. BeiGene recently announced acceptance of 11th regulatory submission for PD-1 Inhibitor Tislelizumab in China.
- Alaunos Therapeutics, Inc. TCRT rose 7.7% to $2.20 in pre-market trading after jumping 20% on Wednesday. Alaunos Therapeutics recently reported better-than-expected Q2 EPS results.
- NetApp, Inc. NTAP rose 6% to $77.20 in pre-market trading after the company reported better-than-expected Q1 results.
- Pinduoduo Inc. PDD rose 5.6% to $56.20 in pre-market trading after gaining over 5% on Wednesday.
Don’t forget to check out our premarket coverage here .
Losers
- Riverview Acquisition Corp. RVAC shares fell 16.4% to $11.57 in pre-market trading after jumping 35% on Wednesday.
- Jowell Global Ltd. JWEL shares fell 15.2% to $1.06 in pre-market trading after gaining more than 12% on Wednesday.
- SuperCom Ltd. SPCB fell 10% to $0.38 in pre-market trading. SuperCom shares jumped 62% on Wednesday after the company announced it was awarded a $33 million national electronic monitoring contract of an EU member country.
- CorpHousing Group Inc. CHG fell 9.8% to $2.31 in pre-market trading. CorpHousing Group recently announced closing of $13.5 million initial public offering.
- Splunk Inc. SPLK fell 9.8% to $99.45 in pre-market trading. Splunk reported better-than-expected results for its second quarter. However, the company said total ARR is expected to be approximately $3.65 billion; Cloud ARR is expected to be roughly $1.8 billion (was previously $3.9 billion and $2.0 billion, respectively).
- AnPac Bio-Medical Science Co., Ltd. ANPC fell 7.8% to $0.3179 in pre-market trading after gaining 38% on Wednesday.
- Comstock Inc. LODE fell 6.7% to $0.56 in pre-market trading after climbing 11% on Wednesday.
- Salesforce, Inc. CRM fell 6.5% to $168.15 in pre-market trading. Salesforce reported upbeat results for its second quarter, but lowered its annual projections.
- Victoria's Secret & Co. VSCO fell 5.7% to $36.17 in pre-market trading after the company reported worse-than-expected Q2 sales results and issued FY23 EPS guidance below estimates.
- Zuora, Inc. ZUO fell 5.7% to $8.44 in pre-market trading after the company reported Q2 results and issued FY23 forecast. Zuora also announced plans to acquire Zephr.
- NVIDIA Corporation NVDA fell 3.4% to $166.30 in pre-market trading as the company reported weaker-than-expected results for its second quarter on Wednesday. Nvidia is guiding for third-quarter revenue of $5.9 billion plus or minus 2%.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: NewsPenny StocksSmall CapPre-Market OutlookMarketsMoversTrading IdeasPremarket MoversTop Gainers
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in